Literature DB >> 11516863

Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma.

E Egger1, A Schalenbourg, L Zografos, L Bercher, T Boehringer, L Chamot, G Goitein.   

Abstract

PURPOSE: This study reports local tumor control and survival after proton beam radiotherapy (PBRT) of uveal melanoma. It identifies the risk factors for local tumor-control failure and for ocular tumor-related death. It presents the improvements implemented to increase the rate of local tumor control, and compares the survival rate of patients with locally controlled tumors to those of patients who had to receive a second treatment. PATIENTS AND METHODS: We have treated 2,435 uveal melanomas with PBRT between March 1984 and December 1998. Data were analyzed as of September 1999. Patients' age ranged from 9 to 89 years; there were 1,188 men and 1,247 women. The largest tumor diameter ranged from 4 to 26 mm, and tumor thickness from 0.9 to 15.6 mm. Median follow-up time was 40 months.
RESULTS: Local tumor control probability at 5 years was improved from 90.6 +/- 1.7% for patients treated before 1988, to 96.3 +/- 0.6% for patients treated between 1989 and 1993, and became 98.9 +/- 0.6% for patients treated after 1993. Among 2,435 treated patients, 73 (3%) had to receive a second treatment because of tumor regrowth. Cause-specific survival at 10 years was calculated to 72.6 +/- 1.9% for patients with controlled tumors compared to 47.5 +/- 6.5% for those with recurrent tumors.
CONCLUSION: Reduced safety margins, large ciliary body tumors, eyelids within the treatment field, inadequate positioning of tantalum clips, and male gender were identified to be the main factors impairing local tumor control. The improvement of local tumor control rate after 1993 is attributed to changes implemented in the treatment procedure. Our data strongly support that the rate of death by metastases is influenced by local tumor control failure: improvement of the local tumor control rate results in a better survival rate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11516863     DOI: 10.1016/s0360-3016(01)01560-7

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  35 in total

1.  Where is the superiority of proton radiation for ocular tumours?

Authors:  Nikolaos E Bechrakis; Michael H Foerster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-07       Impact factor: 3.117

Review 2.  Expanding the therapeutic index of radiation therapy by normal tissue protection.

Authors:  Pierre Montay-Gruel; Lydia Meziani; Chakradhar Yakkala; Marie-Catherine Vozenin
Journal:  Br J Radiol       Date:  2018-07-02       Impact factor: 3.039

3.  18 years' experience with high dose rate strontium-90 brachytherapy of small to medium sized posterior uveal melanoma.

Authors:  R van Ginderdeuren; E van Limbergen; W Spileers
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

Review 4.  Myths and realities of range uncertainty.

Authors:  Antony John Lomax
Journal:  Br J Radiol       Date:  2019-12-23       Impact factor: 3.039

5.  Surgery vs. radiotherapy in patients with uveal melanoma : Analysis of the SEER database using propensity score matching and weighting.

Authors:  Bum-Sup Jang; Ji Hyun Chang; Sohee Oh; Yu Jin Lim; Il Han Kim
Journal:  Strahlenther Onkol       Date:  2017-09-06       Impact factor: 3.621

6.  Outcomes of Proton Beam Radiotherapy for Large Non-Peripapillary Choroidal and Ciliary Body Melanoma at TRIUMF and the BC Cancer Agency.

Authors:  Britta Weber; Katherine Paton; Roy Ma; Tom Pickles
Journal:  Ocul Oncol Pathol       Date:  2015-07-09

7.  Laser and proton radiation to reduce uveal melanoma-associated exudative retinal detachments.

Authors:  Devron H Char; Riley Bove; Theodore L Phillips
Journal:  Trans Am Ophthalmol Soc       Date:  2003

Review 8.  The effectiveness and safety of proton radiation therapy for indications of the eye : a systematic review.

Authors:  Geertruida E Bekkering; Anne W S Rutjes; Vasiliy V Vlassov; Daniel M Aebersold; Konrade von Bremen; Peter Jüni; Jos Kleijnen
Journal:  Strahlenther Onkol       Date:  2009-04-16       Impact factor: 3.621

9.  Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma.

Authors:  Evangelos S Gragoudas; Anne Marie Lane; John Munzenrider; Kathleen M Egan; Wenjun Li
Journal:  Trans Am Ophthalmol Soc       Date:  2002

10.  [Endoresection following proton beam irradiation of large uveal melanomas].

Authors:  N E Bechrakis; S Höcht; P Martus; K M Kreusel; J Heese; M H Foerster
Journal:  Ophthalmologe       Date:  2004-04       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.